Cadrenal Therapeutics, Inc.
CVKD
$5.17
-$0.02-0.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.04M | -2.69M | -3.67M | -3.85M | -4.19M |
| Total Depreciation and Amortization | 600.00 | 400.00 | 400.00 | 5.50K | 400.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 325.10K | 473.40K | 592.60K | 548.80K | 763.20K |
| Change in Net Operating Assets | 143.40K | -145.20K | 48.40K | -1.36M | 1.63M |
| Cash from Operations | -2.57M | -2.36M | -3.03M | -4.65M | -1.79M |
| Capital Expenditure | 0.00 | -1.90K | 0.00 | -3.30K | -6.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -1.90K | 0.00 | -3.30K | -6.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.10M | 684.00K | 1.32M | 2.06M | 3.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -378.50K | -35.60K | -63.70K | -85.30K | 3.94M |
| Cash from Financing | 2.72M | 648.40K | 1.26M | 1.97M | 7.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.70K | -1.71M | -1.77M | -2.68M | 5.65M |